Karabelas Argeris N

DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Aug 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$136K
Net Open-Market Flow
-$136K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2024Sell(S)400$14.59$6K11K
Aug 1, 2024Sell(S)10K$13.45$129K12K
Aug 1, 2024Option exercise(M)100$12.74$1K21K
Aug 1, 2024Option exercise(M)10K$3.76$38K21K
Aug 1, 2024Sell(S)100$15.00$2K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2024Option exercise(M)10K$020K
Aug 1, 2024Option exercise(M)100$01K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-24-006015) within minutes of acceptance. Every field above traces to the original document. Verify it directly: